Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZT-034 in postmenopausal women with low bone mass
NCT01604057Phase 2Unknown
- Sponsor
- Azelon Pharmaceuticals
- Start
- Nov 2011
- Primary completion
- Jul 2012
01
Overview
A Phase 2 trial of ZT-034 in osteoporosis, osteopenia, sponsored by Azelon Pharmaceuticals. Status: unknown.
02
Drugs
ZT-034
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT01604057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01604057.